Amarin Corp Plc (AMRN)

[hamkypamky]

The Ceo of NVS will look at the DCF for 10 yrs exclusivity in the EU
He knows he can make money / profit faster there ,then AMRN ever will .
He has existing Cardio drugs already in that market and a well established marketing infrastructure .
His costs to launch Vascepa in the EU will be substantially less then AMRN's ...and his profit margins a lot higher

He will also appear on CNBC and be forced to explain to his shareholders that he's going to pay $6 for an EU-only partnership to a company currently trading for $3.5 and change. And we all know there's no good way to do that.

It's like seeing a house listed on Zillow for $500k and you decide to offer $1M to lease the ground floor for 50 years "because of the potential", your spouse will be questioning your mental health.

Unless you figure Denner taking over the board will spike the share price up to $5-6 (at least the CEO of NVS can claim that the valuation of the company is only EU to save some face), he'd be laughed out the door.